Data and Information
The AI-backed genomic and clinical data company announced it had laid off about 250 workers in August.
Its technology helps eliminate manual steps in reporting and interpretation of ultrasound images of breast and thyroid.
Its AI mammography solution will support screening exams for 350,000 women annually.
Sonde is its second global digital health investment to date.
NeuTrace focused on developing in-procedure AI tools for electrophysiology.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
Us2.ai announced a similar partnership with Aidoc in October.
Also, Cabrini Technology is adding medical device cybersecurity to its service offerings.
This summer, AIVF announced it had raised $25 million in Series A funding.
Aidoc will integrate Us2.ai's algorithm for analyzing echocardiograms into its proprietary operating system.